Bausch Health Companies BHC
NYSE BHC
$6.06 -0.10 (-1.62%)
As of: Sep 10, 2026 · 3:59 PM EDT

Bausch Health Companies (BHC) Payables (2009 - 2026)

Bausch Health Companies' (BHC) quarterly Payables came in at $593.0 million in Q2 2026, down 5.42% year-over-year from $627.0 million in Q2 2025, and little changed quarter-over-quarter from $593.0 million in Q1 2026.

Analysis

Bausch Health Companies (BHC) Payables (2009 - 2026) Analysis & Trends

Bausch Health Companies has disclosed Payables across 18 years of filings, most recently posting $593.0 million for Q2 2026.

  • In Q2 2026, Payables fell 5.42% year-over-year to $593.0 million; the TTM figure through Jun 2026 stood at $593.0 million (down 5.42% YoY), while the FY2025 annual figure was $600.0 million, up 1.87% from the prior year.
  • Payables came in at $593.0 million for Q2 2026 at Bausch Health Companies, roughly flat from $593.0 million in the prior quarter.
  • In the past five years, Payables ranged from a high of $719.0 million in Q4 2023 to a low of $471.0 million in Q1 2022.
  • Average Payables over 5 years is $583.6 million, with a median of $591.0 million recorded in 2024.
  • Year-over-year, Payables jumped 38.0% in 2023 and dropped 18.08% in 2024.
  • Over 5 years, Payables stood at $521.0 million in 2022, then surged by 38.0% to $719.0 million in 2023, then decreased by 18.08% to $589.0 million in 2024, then advanced by 1.87% to $600.0 million in 2025, then declined by 1.17% to $593.0 million in 2026.
  • Per Business Quant data, the three most recent Payables figures were $593.0 million in Q2 2026, $593.0 million in Q1 2026, and $600.0 million in Q4 2025.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Payables (Qtr)
1 Teva Pharmaceutical Industries 42.33 Bn 38.68 Bn 2.15 Bn 2.72 Bn
2 Viatris 19.05 Bn 18.16 Bn 1.46 Bn 1.73 Bn
3 Dr Reddys Laboratories 9.76 Bn 9.58 Bn 396.53 Mn 449.39 Mn
4 Amneal Pharmaceuticals 5.38 Bn 5.25 Bn 334.51 Mn 721.21 Mn
5 Bausch Health Companies 2.27 Bn 436.38 Mn 2.10 Bn 593.00 Mn
6 Alvotech 1.51 Bn 1.37 Bn 2.56 Mn 171.84 Mn
7 Ani Pharmaceuticals 1.51 Bn 1.15 Bn 165.89 Mn 73.83 Mn
8 Amphastar Pharmaceuticals 1.03 Bn 737.26 Mn 93.47 Mn 251.37 Mn
9 Fennec Pharmaceuticals 393.12 Mn 351.87 Mn 17.15 Mn 5.52 Mn
10 RedHill Biopharma 171.02 Mn 171.02 Mn - 731,000.00
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 593.00 Mn
Mar 31, 2026 593.00 Mn
Dec 31, 2025 600.00 Mn
Sep 30, 2025 616.00 Mn
Jun 30, 2025 627.00 Mn
Mar 31, 2025 620.00 Mn
Dec 31, 2024 589.00 Mn
Sep 30, 2024 667.00 Mn
Jun 30, 2024 579.00 Mn
Mar 31, 2024 642.00 Mn
Dec 31, 2023 719.00 Mn
Sep 30, 2023 569.00 Mn
Jun 30, 2023 515.00 Mn
Mar 31, 2023 561.00 Mn
Dec 31, 2022 521.00 Mn
Sep 30, 2022 486.00 Mn
Jun 30, 2022 536.00 Mn
Mar 31, 2022 471.00 Mn
Dec 31, 2021 407.00 Mn
Sep 30, 2021 455.00 Mn